|
Delayed
Deutsche Boerse AG
02:03:01 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 74.00 EUR | -1.99% |
|
+2.07% | +21.31% |
| 10-06 | EirGenix Submits European Marketing Application for Breast Cancer Biosimilar | MT |
| 10-02 | Weak Jobs Lead to Stronger Stocks |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Sandoz Group AG(SDZ)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Sandoz Group AG(SDZ)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Sandoz Group AG(SDZ)
EBIT
Dividend / Share (DPS)
Data source:
Sandoz Group AG(SDZ)
Cash or Net Debt
- Stock Market
- Stocks
- SDZ Stock
- D8Y0 Stock
- Consensus Sandoz Group AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
